# A Study of NIDO-361 in Patients With SBMA

> **NCT06411912** · PHASE2 · COMPLETED · sponsor: **Nido Biosciences, Inc.** · enrollment: 54 (actual)

## Conditions studied

- Spinal and Bulbar Muscular Atrophy
- Kennedy's Disease

## Interventions

- **DRUG:** NIDO-361
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06411912
- **Lead sponsor:** Nido Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2025-10-22
- **Final completion:** 2025-10-22
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06411912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06411912, "A Study of NIDO-361 in Patients With SBMA". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06411912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*